Eisai Co., Ltd. (ESAIY)
8.105
+0.12
(+1.44%)
USD |
OTCM |
Nov 13, 16:00
Eisai Enterprise Value : 8.931B for Nov. 13, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 13, 2026 | 8.931B |
| November 12, 2026 | 8.801B |
| November 11, 2026 | 8.638B |
| November 10, 2026 | 8.642B |
| November 09, 2026 | 8.801B |
| November 06, 2026 | 8.501B |
| November 05, 2026 | 9.004B |
| November 04, 2026 | 8.683B |
| November 03, 2026 | 8.676B |
| November 02, 2026 | 8.688B |
| October 30, 2026 | 8.755B |
| October 29, 2026 | 8.642B |
| October 28, 2026 | 8.631B |
| October 27, 2026 | 8.858B |
| October 26, 2026 | 8.925B |
| October 23, 2026 | 8.959B |
| October 22, 2026 | 8.857B |
| October 21, 2026 | 8.722B |
| October 20, 2026 | 8.699B |
| October 19, 2026 | 8.484B |
| October 16, 2026 | 8.473B |
| October 15, 2026 | 8.428B |
| October 14, 2026 | 8.123B |
| October 13, 2026 | 7.987B |
| October 12, 2026 | 8.010B |
| Date | Value |
|---|---|
| October 09, 2026 | 8.010B |
| October 08, 2026 | 8.119B |
| October 07, 2026 | 8.032B |
| October 06, 2026 | 8.032B |
| October 05, 2026 | 8.145B |
| October 02, 2026 | 8.190B |
| October 01, 2026 | 8.394B |
| September 30, 2026 | 8.688B |
| September 29, 2026 | 8.649B |
| September 28, 2026 | 9.112B |
| September 25, 2026 | 8.830B |
| September 24, 2026 | 8.897B |
| September 23, 2026 | 8.841B |
| September 22, 2026 | 8.954B |
| September 21, 2026 | 9.010B |
| September 18, 2026 | 8.784B |
| September 17, 2026 | 8.852B |
| September 16, 2026 | 8.717B |
| September 15, 2026 | 8.558B |
| September 14, 2026 | 8.570B |
| September 11, 2026 | 8.445B |
| September 10, 2026 | 8.355B |
| September 09, 2026 | 8.332B |
| September 08, 2026 | 8.361B |
| September 04, 2026 | 8.355B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Takeda Pharmaceutical Co., Ltd. | 94.93B |
| Daiichi Sankyo Co., Ltd. | 31.74B |
| Chugai Pharmaceutical Co., Ltd. | 68.64B |
| Santen Pharmaceutical Co., Ltd. | 3.756B |
| Ono Pharmaceutical Co., Ltd. | 6.362B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 76.10M |
| Revenue (Quarterly) | 1.480B |
| Total Expenses (Quarterly) | 1.406B |
| EPS Diluted (Quarterly) | 0.065 |
| Gross Profit Margin (Quarterly) | 77.30% |
| Profit Margin (Quarterly) | 5.14% |
| Earnings Yield | 3.05% |
| Operating Earnings Yield | 3.46% |
| Normalized Earnings Yield | 3.046 |